Superficial mycoses in immunodepressed patients (AIDS)

Clin Dermatol. 2010 Mar 4;28(2):217-25. doi: 10.1016/j.clindermatol.2009.12.008.

Abstract

HIV infection has the capacity to distort the epidemiology and clinical course of infectious diseases, producing atypical manifestations and changing diagnoses. Superficial fungal infections are frequent in HIV-positive/AIDS patients and are no exception. These infections are frequently different in immunodepressed patients (AIDS), with a modified course or exacerbations. This chapter discusses the diagnosis and treatment of superficial mycoses in HIV patients, including cutaneous alterations caused by Candida, dematiaceous fungi agents of phaeohyphomycosis, Malassezia spp, dermatophyte, and filamentous nondermatophyte fungi.

Publication types

  • Review

MeSH terms

  • AIDS-Related Opportunistic Infections / diagnosis*
  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / epidemiology*
  • Antifungal Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • Candidiasis / drug therapy
  • Candidiasis / epidemiology
  • Dermatomycoses / diagnosis*
  • Dermatomycoses / drug therapy
  • Dermatomycoses / epidemiology*
  • Drug Combinations
  • Humans
  • Incidence
  • Piedra / drug therapy
  • Piedra / epidemiology
  • Risk Factors
  • Tinea / drug therapy
  • Tinea / epidemiology

Substances

  • Antifungal Agents
  • Drug Combinations